Bioelectronics Corp (BIEL)

[ssmmss]

Global Pain Relief Therapy Market is expected to rise from its initial estimated value of USD 1117.61 billion in 2016 to an estimated value of USD 1,849.63 billion by 2026, registering a CAGR of 6.5%in the forecast period of 2016-2026. Increasing investment on R&D is driving the growth of this market.

Some of the major players operating in global pain relief therapy market are Johnson & Johnson Services, Inc., Eli Lilly & Company, Merck & Co. Inc., Pfizer, Inc., Abbott, F. Hoffmann La Roche Ltd., DJO, LLC, Breg, Inc., Beiersdorf AG, Medline Industries, Inc., 3M, Sanofi, ROHTO Pharmaceutical Co., Ltd., Össur Americas, Hisamitsu Pharmaceutical Co., Inc., Calmar Pain Relief, LLC, UltraCare PRO, Polar Products Inc., Agm Overseas, Stimwave LLC, Neurometrix, Niagara, Calmare Therapeutics Incorporated, Iskra Medical d.o.o., THERALASE Technologies Inc., Sombra Professional Therapy Products, Good Health Naturally, Endo Pharmaceuticals Inc., BioElectronics Corporation, HYH, Danaher, ALLERGAN, Purdue Pharma among others.

https://ksusentinel.com/2021/02/04/global-pain-relief-therapy-market-enhancement-latest-trends-growth-and-opportunity-during-2021-to-2028/